Buy, hold, sell: Macquarie, Fortescue, Qantas shares

We review 3 fresh buy, hold, and sell calls from expert market analysts. 

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are 0.6% higher at 9,283 points on Thursday.

Here, three experts give us their views on three ASX 200 shares.

Let's see what they have to say.  

Plane taking off from Sydney airport with CBD in background.

Image source: Getty Images

Macquarie Group Ltd (ASX: MQG)

The Macquarie share price is $266.27, down 0.3% today and up 23% over 12 months. 

Dylan Evans from Catapult Wealth has a buy rating on this ASX 200 bank share. 

Evans said (courtesy The Bull): 

Growth potential for the big four banks is likely to come under pressure from moderating house prices and investment loan demand. We see MQG as a compelling alternative in this environment due to Macquarie's more varied business mix.

Macquarie offers a global range of services that includes investment banking and asset management, which should enable it to offer solid growth even in a slowing retail banking environment.

Macquarie's commodity and markets business can also benefit from market volatility, a useful trait in what is likely to be an uncertain period given the conflict in Iran.

Fortescue Ltd (ASX: FMG)

The Fortescue share price is $18.43, up 1.3% today and down 0.8% over 12 months. 

Bell Potter upgraded the ASX 200 mining share from a sell to a hold call after Fortescue's June quarter report.

Analyst David Coates said:  

FMG's core iron ore operations continue to perform very well and benefit from an elevated iron ore price.

However, higher costs, broad input cost inflation, a subdued iron ore price outlook and potential impacts to price realisation all put pressure on our earnings and dividend forecasts.

We lift our rating to Hold from Sell on recent share price depreciation but do not yet see the positive catalysts to re-enter the stock.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price is $10.69, up 0.8% today and down 3% over 12 months. 

Mark Gardner from MPC Markets has a sell rating on this ASX 200 airline share. 

Gardner said (courtesy The Bull): 

The airline giant is exposed to volatile jet fuel prices in response to the Middle East conflict.

Although QAN hedged about 90 per cent of its exposure to crude oil prices in the second half of 2026, it was exposed to movements in jet refining margins.

Qantas announced in April that jet refining margins had increased from $US20 a barrel in February to a peak of around $US120 a barrel. The company announced capacity adjustments and fare increases to mitigate the impact of the Middle East conflict.

Higher fares may impact demand. We would be inclined to sell into strength.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman in a red dress holding up a red graph.
Broker Notes

Macquarie says these 3 ASX 200 stocks can return 38% to 93%

Three very different companies which could deliver outsized returns.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

Read more »

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »